Company Overview
Company Name
Vaxcyte
Website
vaxcyte.comPhone
(650) 349-4444Approx. Annual Revenue
$30.0M
Employees
200
Established
2019
About Vaxcyte
Vaxcyte is a biopharmaceutical company dedicated to eliminating bacterial infections through the development of innovative vaccines. Their lead candidate, VAX-24, is a 24-valent pneumococcal conjugate vaccine that aims to provide broader protection against invasive pneumococcal disease. Vaxcyte's approach involves re-engineering traditional vaccine production methods using advanced chemistry and synthetic techniques, including their proprietary XpressCF™ cell-free protein synthesis platform.
Business Profile
Read from the Vaxcyte website on Oct 13, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 8/10 · Current news and financials; Detailed pipeline and mission
- Footer copyright year
- 2026
Biotech & Life Sciences Companies near CA
- Immune-Onc Therapeuticsimmune-onc.com
- Santa Cruz Biotechnologyscbt.com
- Alto Neurosciencealtoneuroscience.com
- Palo Alto Veterans Institute for Researchpavir.org
- Kodiak Scienceskodiak.com
- Guardant Healthguardanthealth.com
- AN2 Therapeuticsan2therapeutics.com
- Lytenlyten.com
- PROCEPT BioRoboticsprocept-biorobotics.com
- Orca Bioorcabio.com
Frequently Asked Questions about Vaxcyte
Categories
Technologies Used
Key Decision Makers
Chris Griffith Chief Business and Strategy Officer
Harp Dhaliwal Chief Technical Operations Officer
Whitney Jones Chief People Officer
Jim Wassil Executive Vice President, Chief Operating Officer and Chief Scientific Officer
Grant Pickering Chief Executive Officer, Director and Co-Founder
Luis Jodar Chief Medical Officer
Mike Mullette Chief Commercial Officer
Alexandra Paschenko Clinical Trial Manager
Susie Kamath Director, Clinical Outsourcing
Emma Gierman Senior Clinical Trials Manager